Bexion Pharmaceuticals
Olivier Rixe is a Clinical & Scientific Advisor at Bexion Pharmaceuticals. Olivier has also served as VP-Early Clinical Development at Daiichi Sankyo, Inc., Founder, Director and Principal Investigator at Quantum Santa Fe, Cancer Center Associate Director, Clinical Research/Professor of Medicine at University of New Mexico Comprehensive Cancer Center, and Director, Experimental Therapeutics Program/Professor of Medicine at Medical College of Georgia at Georgia Regents University. Olivier Rixe has also been a Staff Clinician at National Cancer Institute and Professor of Medicine/Medical Oncology at Pierre and Marie Curie University.
Olivier Rixe holds a PhD in Molecular Biology from Université de Paris, as well as a Doctor of Medicine from Pierre and Marie Curie University.
This person is not in the org chart
This person is not in any offices
Bexion Pharmaceuticals
Bexion Pharmaceuticals is committed to the discovery and clinical development of life-changing oncology treatments. Bexion focuses on helping patients and their families living with cancer, where there is a significant unmet need.